Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 14 studies | 54% ± 21% | |
glutamatergic neuron | 9 studies | 51% ± 24% | |
GABAergic neuron | 8 studies | 44% ± 27% | |
astrocyte | 6 studies | 25% ± 13% | |
interneuron | 6 studies | 41% ± 24% | |
type II pneumocyte | 5 studies | 30% ± 9% | |
neuron | 4 studies | 25% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 35% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 7162.34 | 2613 / 2642 | 100% | 44.60 | 703 / 705 |
adrenal gland | 100% | 4020.68 | 258 / 258 | 90% | 8.37 | 206 / 230 |
lung | 83% | 1264.68 | 482 / 578 | 57% | 2.06 | 664 / 1155 |
bladder | 71% | 465.62 | 15 / 21 | 55% | 1.95 | 276 / 504 |
pancreas | 77% | 825.32 | 254 / 328 | 41% | 0.97 | 73 / 178 |
skin | 85% | 1148.23 | 1529 / 1809 | 25% | 1.83 | 118 / 472 |
esophagus | 65% | 440.20 | 933 / 1445 | 39% | 1.08 | 72 / 183 |
breast | 68% | 791.88 | 314 / 459 | 34% | 0.77 | 378 / 1118 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.07 | 1 / 1 |
thymus | 22% | 115.41 | 142 / 653 | 75% | 3.28 | 455 / 605 |
intestine | 62% | 506.46 | 599 / 966 | 34% | 1.05 | 179 / 527 |
uterus | 51% | 539.83 | 87 / 170 | 41% | 1.92 | 188 / 459 |
stomach | 30% | 232.71 | 109 / 359 | 37% | 1.37 | 107 / 286 |
prostate | 56% | 383.56 | 138 / 245 | 7% | 0.12 | 35 / 502 |
kidney | 42% | 271.92 | 37 / 89 | 12% | 0.48 | 105 / 901 |
adipose | 37% | 247.44 | 440 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 24% | 0.56 | 11 / 45 |
blood vessel | 18% | 107.69 | 240 / 1335 | 0% | 0 | 0 / 0 |
heart | 17% | 98.54 | 147 / 861 | 0% | 0 | 0 / 0 |
ovary | 7% | 55.27 | 12 / 180 | 9% | 0.20 | 37 / 430 |
liver | 0% | 0 | 0 / 226 | 7% | 0.12 | 29 / 406 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.10 | 2 / 29 |
eye | 0% | 0 | 0 / 0 | 4% | 0.09 | 3 / 80 |
spleen | 0% | 1.52 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.62 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007173 | Biological process | epidermal growth factor receptor signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0007417 | Biological process | central nervous system development |
GO_0005575 | Cellular component | cellular_component |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
GO_0001784 | Molecular function | phosphotyrosine residue binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | SHC3 |
Protein name | SHC adaptor protein 3 SHC-transforming protein 3 (Neuronal Shc) (N-Shc) (Protein Rai) (SHC-transforming protein C) (Src homology 2 domain-containing-transforming protein C3) (SH2 domain protein C3) |
Synonyms | NSHC SHCC |
Description | FUNCTION: Signaling adapter that couples activated growth factor receptors to signaling pathway in neurons. Involved in the signal transduction pathways of neurotrophin-activated Trk receptors in cortical neurons. |
Accessions | Q5T7I8 ENST00000375831.1 Q92529 ENST00000375835.9 [Q92529-1] |